$JKSM
Jacksam Corp Stock $jksm

$jksm Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000147793224002155 Filed on April 16, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023
Revenue	$136.3K	$234.1K	$1.456M
YoY Change	-66.14%	-40.16%	-64.74%
Cost Of Revenue	$84.27K	$471.3K	$1.217M
YoY Change	-65.96%	1.21%	-63.1%
Gross Profit	$52.04K	-$237.2K	$239.0K
YoY Change	-66.43%	218.43%	-71.22%
Gross Profit Margin	38.18%	-101.34%	16.42%
Selling, General & Admin	-$87.29K	$59.96K	$557.8K
YoY Change	-195.84%	-90.28%	-42.51%
% of Gross Profit	-167.73%		233.35%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$30.00	$100.00	$390.00
YoY Change		0.0%	-59.16%
% of Gross Profit	0.06%		0.16%
Operating Expenses	-$87.29K	$59.97K	$557.8K
YoY Change	-161.32%	-90.28%	-71.12%
Operating Profit	$139.3K	-$297.2K	-$318.7K
YoY Change	999.63%	-57.01%	-71.05%
Interest Expense	$84.00K	-$422.7K	-$966.7K
YoY Change	-33.26%	-16.49%	-328.99%
% of Operating Profit	60.29%
Other Income/Expense, Net	-$84.00K	$0.00	$26.23K
YoY Change	-94.93%		-54.25%
Pretax Income	$55.33K	-$719.9K	-$1.259M
YoY Change	-103.35%	-39.88%	-162.03%
Income Tax
% Of Pretax Income
Net Earnings	$55.33K	-$743.3K	-$1.352M
YoY Change	-103.36%	-39.12%	-11.15%
Net Earnings / Revenue	40.59%	-317.5%	-92.85%
Basic Earnings Per Share	$0.00		-$0.02
Diluted Earnings Per Share	$0.00	-$0.01	-$0.02
COMMON SHARES
Basic Shares Outstanding	94.66M shares	81.09M shares	81.09M shares
Diluted Shares Outstanding	93.63M shares		81.09M shares

Balance Sheet

Concept	2024 Q2	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$67.62K	$145.5K	$145.5K
YoY Change	-32.38%	-69.87%	-69.87%
Cash & Equivalents	$67.62K	$145.5K
Short-Term Investments
Other Short-Term Assets	$35.34K	$77.63K	$77.63K
YoY Change	-11.65%	85.94%	85.94%
Inventory	$131.00	$0.00	$0.00
Prepaid Expenses	$35.34K	$77.63K
Receivables	$18.12K	$9.520K	$9.520K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$121.2K	$232.7K	$232.7K
YoY Change	-66.5%	-68.51%	-68.51%
LONG-TERM ASSETS
Property, Plant & Equipment	$0.00	$44.09K	$44.09K
YoY Change	-100.0%	8428.05%	-43.61%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$25.78K	$44.09K	$44.09K
YoY Change	-58.13%	-43.61%	-43.62%
TOTAL ASSETS
Total Short-Term Assets	$121.2K	$232.7K	$232.7K
Total Long-Term Assets	$25.78K	$44.09K	$44.09K
Total Assets	$147.0K	$276.8K	$276.8K
YoY Change	-65.28%	-66.13%	-66.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$255.1K	$292.9K	$292.9K
YoY Change	-12.02%	19.32%	19.32%
Accrued Expenses	$2.263M	$2.145M	$2.145M
YoY Change	9.86%	7.81%	7.81%
Deferred Revenue
YoY Change
Short-Term Debt	$50.00K	$50.00K	$50.00K
YoY Change	0.0%
Long-Term Debt Due	$1.773M	$1.064M	$1.064M
YoY Change	65.69%	76.48%	76.48%
Total Short-Term Liabilities	$5.772M	$5.115M	$5.115M
YoY Change	-14.27%	1.53%	1.53%
LONG-TERM LIABILITIES
Long-Term Debt	$135.9K	$138.0K	$138.0K
YoY Change	-2.93%	-76.22%	-76.22%
Other Long-Term Liabilities	$0.00	$6.980K	$6.980K
YoY Change	-100.0%	-84.9%	-84.9%
Total Long-Term Liabilities	$135.9K	$145.0K	$145.0K
YoY Change	-20.06%	-76.86%	-76.86%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.772M	$5.115M	$5.115M
Total Long-Term Liabilities	$135.9K	$145.0K	$145.0K
Total Liabilities	$5.908M	$5.260M	$5.260M
YoY Change	-14.38%	-7.14%	-7.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.40M	-$13.91M
YoY Change	1.13%	9.95%
Common Stock	$89.72K	$81.09K
YoY Change	10.64%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$6.052M	-$4.983M	-$4.983M
YoY Change
Total Liabilities & Shareholders Equity	$147.0K	$276.8K	$276.8K
YoY Change	-65.28%	-66.13%	-66.13%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$55.33K	-$743.3K	-$1.352M
YoY Change	-103.36%	-39.12%	-11.15%
Depreciation, Depletion And Amortization	$30.00	$100.00	$390.00
YoY Change		0.0%	-59.16%
Cash From Operating Activities	-$29.52K	$5.220K	-$311.4K
YoY Change	-67.2%	-97.17%	-15.98%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-7.290K	-5.230K	-25.97K
YoY Change	-27.1%	1088.64%	-105.1%
NET CHANGE
Cash From Operating Activities	-29.52K	5.220K	-311.4K
Cash From Investing Activities
Cash From Financing Activities	-7.290K	-5.230K	-25.97K
Net Change In Cash	-36.81K	-10.00	-337.4K
YoY Change	-63.19%	-100.01%	-344.31%
FREE CASH FLOW
Cash From Operating Activities	-$29.52K	$5.220K	-$311.4K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	482908	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	0	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	214143	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	232661	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	128	usd
CY2023Q4	us-gaap	Assets Assets	276754	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	756456	usd
CY2022Q4	us-gaap	Assets Assets	816996	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13911476	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12652285	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-5267658	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-5119181	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	276754	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	816996	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	9515	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	77625	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	43965	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	77677	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	902485	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1127634	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5114840	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	145521	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	558879	usd
CY2023Q4	us-gaap	Line Of Credit LineOfCredit	50000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6978	usd
CY2023Q4	us-gaap	Liabilities Liabilities	5259790	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1642269	usd
CY2022Q4	us-gaap	Liabilities Liabilities	5664155	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	81088	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	81088	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	8562630	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	7451916	usd
CY2022	us-gaap	Interest Expense InterestExpense	422158	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	41751	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	738802	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	517	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	80000	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	444444	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	158672	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	491913	usd
CY2022Q4	jksm	Subscription Payable Current SubscriptionPayableCurrent	499999	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5037817	usd
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	580105	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	46233	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1259191	usd
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.29
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000860543
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81088719	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81088719	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81088719	shares
CY2023	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	31825	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022	jksm	Aggregate Number Ending AggregateNumberEnding	14279965	shares
CY2022	jksm	Aggregate Exercise Price Ending AggregateExercisePriceEnding	2946044	usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2022	jksm	Weighted Average Exercise Price Ending WeightedAverageExercisePriceEnding	0.21
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	2777778	shares
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	033-33263
CY2023	dei	Entity Registrant Name EntityRegistrantName	JACKSAM CORPORATION
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-3566284
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	3100 Airway Avenue
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 138
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Costa Mesa
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92626
CY2023	dei	City Area Code CityAreaCode	800
CY2023	dei	Local Phone Number LocalPhoneNumber	605-3580
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2023	dei	Trading Symbol TradingSymbol	JKSM
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	2420000	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	94663320	shares
CY2023	dei	Auditor Name AuditorName	M&K CPAS, PLLC
CY2023	dei	Auditor Firm AuditorFirmId	2738
CY2023	dei	Auditor Location AuditorLocation	The Woodlands, TX
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	usd
CY2023Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	160000	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	444444	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	619932	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	0	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	39255	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	34007	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1642269	usd
CY2023Q4	jksm	Subscription Payable Current SubscriptionPayableCurrent	499999	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	0	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	94095	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	137972	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	284622	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	272022	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	30000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81088719	shares
CY2023	us-gaap	Revenues Revenues	1455880	usd
CY2022	us-gaap	Revenues Revenues	4128456	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1216845	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3297955	usd
CY2023	us-gaap	Gross Profit GrossProfit	239035	usd
CY2022	us-gaap	Gross Profit GrossProfit	830501	usd
CY2023	us-gaap	Salaries And Wages SalariesAndWages	201731	usd
CY2022	us-gaap	Salaries And Wages SalariesAndWages	961069	usd
CY2023	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	356043	usd
CY2022	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	970267	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	557774	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1931336	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-318739	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1100835	usd
CY2023	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-711401	usd
CY2022	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	1515	usd
CY2023	us-gaap	Interest Expense InterestExpense	255278	usd
CY2023	us-gaap	Other Income OtherIncome	26227	usd
CY2022	us-gaap	Other Income OtherIncome	0	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-940452	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-420643	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1259191	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1521478	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	92600	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	92600	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1351791	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1614078	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81088719	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79302098	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81088719	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79302098	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-4514303	usd
CY2022	jksm	Issuance Of Series B Preferred Stock Net Of Fees Amount IssuanceOfSeriesBPreferredStockNetOfFeesAmount	890000	usd
CY2022	jksm	Common Stock Issued For Share Payable Amount CommonStockIssuedForSharePayableAmount	0	usd
CY2022	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	119200	usd
CY2022	jksm	Common Stock And Warrants Issued In Connection With Preferred Stock Amount CommonStockAndWarrantsIssuedInConnectionWithPreferredStockAmount	0	usd
CY2022	jksm	Dividends On Series A And B Preferred Stock DividendsOnSeriesAAndBPreferredStock	-92600	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-1521478	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-5119181	usd
CY2023	jksm	Reclassification Of Derivative Liability To Equity ReclassificationOfDerivativeLiabilityToEquity	1203314	usd
CY2023	jksm	Dividends On Series A And B Preferred Stock DividendsOnSeriesAAndBPreferredStock	-92600	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-5267658	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-1259191	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-1521478	usd
CY2023	us-gaap	Depreciation Depreciation	389	usd
CY2022	us-gaap	Depreciation Depreciation	955	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	0	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	76978	usd
CY2022	us-gaap	Interest And Debt Expense InterestAndDebtExpense	190659	usd
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	95095	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	70485	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	33712	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	28145	usd
CY2023	us-gaap	Interest Expense Other InterestExpenseOther	0	usd
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	167620	usd
CY2023	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-711401	usd
CY2022	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	1515	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2023	jksm	Impairment Of Inventory ImpairmentOfInventory	0	usd
CY2022	jksm	Impairment Of Inventory ImpairmentOfInventory	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9515	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-400510	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-214143	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	17431	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	35874	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	33151	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-34007	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-25582	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	197577	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-40591	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-225149	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	333742	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-311419	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-370654	usd
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	50000	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2023	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	300000	usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1000	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	327385	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	74968	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	408634	usd
CY2023	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	890000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-25968	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	508751	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-337387	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	138097	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	482908	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	344811	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	145521	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	482908	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023	us-gaap	Interest Paid InterestPaid	8691	usd
CY2022	us-gaap	Interest Paid InterestPaid	19699	usd
CY2023	jksm	Right Of Use Asset And Liability Recognized Operating Leases RightOfUseAssetAndLiabilityRecognizedOperatingLeases	0	usd
CY2022	jksm	Right Of Use Asset And Liability Recognized Operating Leases RightOfUseAssetAndLiabilityRecognizedOperatingLeases	105822	usd
CY2023	jksm	Common Stock Issued For Deferred Finance Costs CommonStockIssuedForDeferredFinanceCosts	0	usd
CY2022	jksm	Common Stock Issued For Deferred Finance Costs CommonStockIssuedForDeferredFinanceCosts	2670	usd
CY2023	jksm	Common Stock Issued To Settle Share Payable CommonStockIssuedToSettleSharePayable	0	usd
CY2022	jksm	Common Stock Issued To Settle Share Payable CommonStockIssuedToSettleSharePayable	331600	usd
CY2023	jksm	Loss On Additional Shares Issued In Connection With Common Stock Units LossOnAdditionalSharesIssuedInConnectionWithCommonStockUnits	0	usd
CY2022	jksm	Loss On Additional Shares Issued In Connection With Common Stock Units LossOnAdditionalSharesIssuedInConnectionWithCommonStockUnits	42222	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	92600	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	92600	usd
CY2023	jksm	Settlement Of Derivative Liabilities SettlementOfDerivativeLiabilities	1203314	usd
CY2022	jksm	Settlement Of Derivative Liabilities SettlementOfDerivativeLiabilities	0	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements is in conformity with U.S. GAAP and requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Such estimates and assumptions impact both assets and liabilities, including but not limited to net realizable value of accounts receivable and inventory, estimated useful lives and potential impairment of property and equipment, estimate of fair value of share-based payments and derivative liabilities, estimates of fair value of warrants issued and recorded as debt discount and estimates of the probability and potential magnitude of contingent liabilities. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future nonconforming events. Accordingly, actual results could differ significantly from estimates.</p>
CY2023	us-gaap	Federal Deposit Insurance Corporation Premium Expense FederalDepositInsuranceCorporationPremiumExpense	250000	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	264659	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	264659	usd
CY2023	jksm	Bad Debts Expense BadDebtsExpense	0	usd
CY2022	jksm	Bad Debts Expense BadDebtsExpense	190659	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	9515	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	0	usd
CY2023	jksm	Inventory Allowance InventoryAllowance	244658	usd
CY2022	jksm	Inventory Allowance InventoryAllowance	18800	usd
CY2023	jksm	Reserves For Inventory ReservesForInventory	274052	usd
CY2022	jksm	Reserves For Inventory ReservesForInventory	0	usd
CY2023	jksm	Description Of Performance Obligation DescriptionOfPerformanceObligation	Pure Plan, Native Nation, and ARK are the only 10%+ customers in 2023. When these customers are aggregated, they equal 57% of the 2023 sales.
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	902485	usd
CY2023	jksm	Summary Of Effect Of Potential Dilutive Issuances SummaryOfEffectOfPotentialDilutiveIssuances	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:92%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Year Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, 2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, 2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net income (loss) attributable to common stockholders</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,351,791 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,614,078 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Preferred stock dividends</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">92,600</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">92,600</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Derivative gain</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">711,401</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(1,515 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Interest expense associated with convertible debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">98,265</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Net income (loss) for dilutive calculation</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(547,790 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">(1,424,728 </td><td style="PADDING-BOTTOM: 3px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Weighted average shares outstanding</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">81,088,719</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">79,302,098</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dilutive effect of preferred stock</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dilutive effect of convertible debt</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dilutive effect of common stock warrants</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Weighted average shares outstanding for diluted net income (loss) per share</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">81,088,719</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">79,302,098</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2023	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-1351791	usd
CY2022	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-1614078	usd
CY2023	jksm	Dividends Preferred Stock1 DividendsPreferredStock1	92600	usd
CY2022	jksm	Dividends Preferred Stock1 DividendsPreferredStock1	92600	usd
CY2023	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	711401	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1515	usd
CY2022	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	98265	usd
CY2023	jksm	Net Income Loss For Dilutive Calculation NetIncomeLossForDilutiveCalculation	-547790	usd
CY2022	jksm	Net Income Loss For Dilutive Calculation NetIncomeLossForDilutiveCalculation	-1424728	usd
CY2023	jksm	Weighted Average Shares Outstanding WeightedAverageSharesOutstanding	81088719	usd
CY2022	jksm	Weighted Average Shares Outstanding WeightedAverageSharesOutstanding	79302098	usd
CY2022	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	0	usd
CY2023	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	0	usd
CY2023	jksm	Dilutive Effect Of Convertible Debt DilutiveEffectOfConvertibleDebt	0	usd
CY2022	jksm	Dilutive Effect Of Convertible Debt DilutiveEffectOfConvertibleDebt	0	usd
CY2023	jksm	Dilutive Effect Of Common Stock Warrants DilutiveEffectOfCommonStockWarrants	0	usd
CY2022	jksm	Dilutive Effect Of Common Stock Warrants DilutiveEffectOfCommonStockWarrants	0	usd
CY2023	jksm	Weighted Average Shares Outstanding For Diluted Net Income Loss Per Share WeightedAverageSharesOutstandingForDilutedNetIncomeLossPerShare	81088719	usd
CY2022	jksm	Weighted Average Shares Outstanding For Diluted Net Income Loss Per Share WeightedAverageSharesOutstandingForDilutedNetIncomeLossPerShare	79302098	usd
CY2023	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	12068576	shares
CY2023	jksm	Effect Of Convertible Debt Shares EffectOfConvertibleDebtShares	44444444	shares
CY2023	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	18066667	shares
CY2022	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	14279965	shares
CY2022	jksm	Effect Of Convertible Debt Shares EffectOfConvertibleDebtShares	75585790	shares
CY2022	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	18066667	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2777778	shares
CY2023	us-gaap	Depreciation Depreciation	389	usd
CY2022	us-gaap	Depreciation Depreciation	955	usd
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	619	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	58739	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20644	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20644	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20516	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20127	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	128	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	517	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	756456	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	558879	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	757904	usd
CY2022Q4	us-gaap	Notes Payable NotesPayable	832872	usd
CY2023Q4	jksm	Debt Instrument Unamortized Discount1 DebtInstrumentUnamortizedDiscount1	0	usd
CY2022Q4	jksm	Debt Instrument Unamortized Discount1 DebtInstrumentUnamortizedDiscount1	94095	usd
CY2023Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	619932	usd
CY2022Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	158672	usd
CY2023Q4	jksm	Notes Payable Net Of Current Portion NotesPayableNetOfCurrentPortion	137972	usd
CY2022Q4	jksm	Notes Payable Net Of Current Portion NotesPayableNetOfCurrentPortion	580105	usd
CY2023Q1	jksm	Penalty Amount Not Yet Assesed PenaltyAmountNotYetAssesed	450000	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	95095	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	27215	usd
CY2023Q4	jksm	Principal Amount PrincipalAmount	50000	usd
CY2023	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.10	pure
CY2023	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-06-30
CY2023	us-gaap	Deferred Purchased Power Costs DeferredPurchasedPowerCosts	1000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	619932	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3440	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3588	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3727	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	4193	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	173024	usd
CY2023Q4	jksm	Total Remaining Intangibles Amortization TotalRemainingIntangiblesAmortization	807904	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	444444	usd
CY2022Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	444444	usd
CY2023Q4	jksm	Current Convertible Notes Payable Net Of Discount CurrentConvertibleNotesPayableNetOfDiscount	-444444	usd
CY2022Q4	jksm	Current Convertible Notes Payable Net Of Discount CurrentConvertibleNotesPayableNetOfDiscount	-444444	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	0	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	0	usd
CY2023	jksm	Convertible Notes Payable1 ConvertibleNotesPayable1	444444	usd
CY2024Q1	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	685713	shares
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	318991	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	169874	usd
CY2023	jksm	Total Gain TotalGain	-711401	usd
CY2022	jksm	Total Gain TotalGain	1515	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	jksm	Common Stock Designated CommonStockDesignated	200000000	shares
CY2021Q4	jksm	Preferred Stock Designated PreferredStockDesignated	30000000	shares
CY2021Q4	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.18
CY2021Q4	us-gaap	Share Price SharePrice	0.18
CY2021Q4	jksm	Stock Exercise Price StockExercisePrice	0.27
CY2023	jksm	Shares Remaining To Be Issued SharesRemainingToBeIssued	2222223	shares
CY2023	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	2777778	shares
CY2023Q4	jksm	Subscriptions Payable Liability Balance SubscriptionsPayableLiabilityBalance	499999	usd
CY2023Q4	jksm	Common Stock Share Issued CommonStockShareIssued	2670034	shares
CY2023	jksm	Fair Value Of Common Stock FairValueOfCommonStock	139800	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	24220	usd
CY2023	us-gaap	Lease Cost LeaseCost	48000	usd
CY2022	us-gaap	Lease Cost LeaseCost	61086	usd
CY2022	jksm	Aggregate Number Beginning AggregateNumberBeginning	11189056	shares
CY2022	jksm	Aggregate Exercise Price Beginning AggregateExercisePriceBeginning	2646044	usd
CY2022	jksm	Weighted Average Exercise Price Beginning WeightedAverageExercisePriceBeginning	0.24
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	4000000	shares
CY2022	jksm	Aggregate Exercise Price Granted AggregateExercisePriceGranted	800000	usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.20
CY2022	jksm	Aggregate Exercise Price Exercised1 AggregateExercisePriceExercised1	-909091	usd
CY2022	jksm	Aggregate Exercise Price Exercised AggregateExercisePriceExercised	500000	usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.45
CY2022	jksm	Less Forfeited And Cancelled LessForfeitedAndCancelled	0	usd
CY2022	jksm	Aggregate Exercise Price Forfeited And Cancelled AggregateExercisePriceForfeitedAndCancelled	0	usd
CY2023	jksm	Aggregate Number Beginning AggregateNumberBeginning	14279965	shares
CY2023	jksm	Aggregate Exercise Price Beginning AggregateExercisePriceBeginning	2946044	usd
CY2023	jksm	Weighted Average Exercise Price Beginning WeightedAverageExercisePriceBeginning	0.21
CY2023	jksm	Aggregate Exercise Price Granted AggregateExercisePriceGranted	0	usd
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023	jksm	Less Forfeited And Cancelled LessForfeitedAndCancelled	-2211389	usd
CY2023	jksm	Aggregate Exercise Price Forfeited And Cancelled AggregateExercisePriceForfeitedAndCancelled	631200	usd
CY2023	jksm	Aggregate Number Ending AggregateNumberEnding	12068576	shares
CY2023	jksm	Aggregate Exercise Price Ending AggregateExercisePriceEnding	2088177	usd
CY2023	jksm	Weighted Average Exercise Price Ending WeightedAverageExercisePriceEnding	0.17
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P1Y3M25D
CY2023Q4	jksm	Debt Intrinsic Value DebtIntrinsicValue	18667	usd
CY2023	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	3267	usd
CY2023	jksm	Lease Payments Increased Percentage LeasePaymentsIncreasedPercentage	0.04	pure
CY2023Q4	jksm	Right Of Use Asset And Lease Liability RightOfUseAssetAndLeaseLiability	105822	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	40217	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	36866	usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	7783	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	43965	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	77677	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	39255	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	34007	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6978	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	46233	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	46233	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	80240	usd
CY2023Q4	jksm	Incremental Borrowing Rate Percentage IncrementalBorrowingRatePercentage	0.10	pure
CY2023	jksm	Lease Remaining Terms LeaseRemainingTerms	P1Y2M1D
CY2023Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.10	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	42123	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	7065	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2023Q4	jksm	Lessee Operating Lease Liability Payments Due After Year Six LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix	0	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	49188	usd
CY2023Q4	jksm	Less Interest Lessee Operating Lease Liability LessInterestLesseeOperatingLeaseLiability	2955	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	46233	usd
CY2023Q4	jksm	Accrued Liabilities Other AccruedLiabilitiesOther	1642269	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2118207	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2029845	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1900	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2118207	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2031745	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2118207	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2031537	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	208	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts	208	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0210	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0659	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	-0.1613	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization	-0.0581	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.0687	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2207	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Other EffectiveIncomeTaxRateReconciliationTaxSettlementsOther	-0.0011	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Other EffectiveIncomeTaxRateReconciliationTaxSettlementsOther	0.0029	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.0000	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.0000	pure
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	631000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	7190000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	6828000	usd
CY2024Q1	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	685713	shares

Files In Submission

Name	View Source	Status
0001477932-24-002155-index-headers.html	Edgar Link	pending
0001477932-24-002155-index.html	Edgar Link	pending
0001477932-24-002155.txt	Edgar Link	pending
0001477932-24-002155-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
jksm-20231231.xsd	Edgar Link	pending
jksm_10k.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
jksm-20231231_cal.xml	Edgar Link	unprocessable
jksm-20231231_def.xml	Edgar Link	unprocessable
jksm-20231231_lab.xml	Edgar Link	unprocessable
jksm-20231231_pre.xml	Edgar Link	unprocessable
jksm_10k_htm.xml	Edgar Link	completed
jksm_ex311.htm	Edgar Link	pending
jksm_ex321.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$JKSM
Jacksam Corp Stock $jksm

2024 Q2 Form 10-K Financial Statement

#000147793224002155 Filed on April 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JKSM Jacksam Corp Stock $jksm

2024 Q2 Form 10-K Financial Statement

#000147793224002155 Filed on April 16, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$JKSM
Jacksam Corp Stock $jksm